Intrathecal pain pump infusions for intractable cancer pain: An algorithm for dosing without a neuraxial trial

Anesthesia and Analgesia

Volumn 116, Issue 6, 2013, Pages 1364-1370

  Malhotra, Vivek Tim ^a   Root, James ^a   Kesselbrenner, Joseph ^a   Njoku, Innocent ^b   Cubert, Kenneth ^a   Gulati, Amitabh ^a   Puttanniah, Vinay ^a   Bilsky, Mark ^a   Kaplitt, Michael ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CLONIDINE; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE;

ADULT; ALGORITHM; ARTICLE; CANCER PAIN; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTRACTABLE PAIN; INTRATHECAL PUMP; MALE; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANALGESIA, EPIDURAL; ANALGESICS, OPIOID; FEMALE; HUMANS; INFUSION PUMPS; INJECTIONS, SPINAL; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASMS; PAIN, INTRACTABLE;

EID: 84878391147     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31828d670e     Document Type: Article

References (8)

1. Smith TJ, Coyne PJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Català E, Bryce DA, Cousins M, Pool GE. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). Ann Oncol 2005;16:825-33 (Pubitemid 40767106)
2. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Catala E, Bryce DA, Coyne PJ, Pool GE. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002;20:4040-9
3. Kelsen DP, Portenoy RK, Thaler HT, Niedzwiecki D, Passik SD, Tao Y, Banks W, Brennan MF, Foley KM. Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 1995;13:748-55
4. Du Pen SL, Williams AR. The dilemma of conversion from systemic to epidural morphine: a proposed conversion tool for treatment of cancer pain. Pain 1994;56:113-8
5. Paice JA, Cohen FL. Validity of a verbally administered numeric rating scale to measure cancer pain intensity. Cancer Nurs 1997;20:88-93 (Pubitemid 27200354)
6. Deer TR, Smith HS, Burton AW, Pope JE, Doleys DM, Levy RM, Staats PS, Wallace MS, Webster LR, Rauck RL, Cousins M. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician 2011;14:E283-312
7. Hassenbusch SJ, Paice JA, Patt RB, Bedder MD, Bell GK. Clinical realities and economic considerations: economics of intrathecal therapy. J Pain Symptom Manage 1997;14:S36-48 (Pubitemid 27377606)
8. Foley KM. The treatment of cancer pain. N Engl J Med 1985;313:84-95 (Pubitemid 15068702)